Medical Communications

Showing 15 posts of 6408 posts found.

Visit Us! DIA’s Refreshed Homepage Design

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …

PrimeVigilance celebrates its 10th anniversary

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …
shutterstock_79370437

Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso

April 13, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
180405-evolution-of-kidney-cancer

Evolutionary path of kidney cancer tracked, “born to be bad” type discovered

April 13, 2018 Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
eisa0003

Eisai forms partnership to find new tuberculosis treatment

April 13, 2018 Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
roche__tree

Roche’s immunotherapy lucky streak ends with deaths in trial

April 13, 2018 Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
photo_ivana_magovcevic-liebisch3

Ipsen bolsters executive leadership with two new recruits

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
satu1028-pano_1024_px

EMA announces second-ever public hearing on high-use antibiotics

April 12, 2018 Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …
kris-sterkens-23052017-hr-1

Working Life: Kris Sterkens, Company Group Chairman, Janssen EMEA

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, Kris Sterkens, pharma

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018 Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
kenneth-newman_credit_verona_pharma

Verona Pharma loses Chief Medical Officer

April 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
theresa_may_-_credit_arno_mikkor

May announces £75m prostate cancer boost

April 10, 2018 Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …
woman-1246587_960_720

Media reports over Parkinson’s drug risk hit Acadia hard

April 10, 2018 Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical

Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …
The Gateway to Local Adoption Series

Latest content